AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18807128
Drug: omeprazole 10
RxNorm normalized name: omeprazole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omeprazole 10 mg
Trial: 1742515
Drug: ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ranitidine 150 mg
Trial: 1745027
Drug: Drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug therapy only (control group)
Trial: 29094048
Drug: Single-dose Praziquantel
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose Praziquantel (40 mg/kg)
Trial: 29094048
Drug: Double-dose Praziquantel
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Double-dose Praziquantel (40 mg/kg)
Trial: 19229988
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose budesonide (9 mg/day for 7 weeks followed by 6 mg/day for 3 weeks)
Trial: 19229988
Drug: Induction with
RxNorm normalized name: Marcaine with Epinephrine Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction with 12 mg/day for the first month followed by the same regimen as Group 1
Trial: 17698116
Drug: Preoperative circulating
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative circulating plasminogen activator inhibitor type I
Trial: 17698116
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of plasminogen activator inhibitor type I to preoperative multivariate model
Trial: 17698116
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of plasminogen activator inhibitor type I to postoperative model
Trial: 10928308
Drug: Tiapride 100-300
RxNorm normalized name: tiapride
DrugBank: Tiapride (DB13025)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiapride 100-300 mg/day
Trial: 10928308
Drug: Haloperidol 2-6
RxNorm normalized name: haloperidol 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 2-6 mg/day
Trial: 8677757
Drug: Effective chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Effective chemotherapy in ANLL responders
Trial: 8677757
Drug: Granulocyte-macrophage colony-stimulating
RxNorm normalized name: Granulocyte macrophage-colony stimulating factor
DrugBank: Molgramostim (DB12525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy in ANLL responders
Trial: 29602597
Drug: Atypical antipsychotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atypical antipsychotic drugs (monotherapy for 6 weeks)
Trial: 25565583
Drug: Pregabalin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (150 to 300 mg/d)
Trial: 25332243
Drug: High-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon (HDI) for 1 year
Trial: 15968712
Drug: Flutin capsules
RxNorm normalized name: azelastine
DrugBank: Azelastine (DB00972)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutin capsules (Julphar, UAE)
Trial: 15968712
Drug: Prozac capsules
RxNorm normalized name: fluoxetine Oral Capsule [Prozac]
DrugBank: Fluoxetine (DB00472)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prozac capsules (Eli Lilly, UK)
Trial: 12110467
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of oral amphetamine
Trial: 8822427
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of prednisolone daily for 2 weeks prior to IVF treatment
Trial: 8822427
Drug: Placebo daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo daily for 2 weeks prior to IVF treatment
Trial: 12542874
Drug: Subarachnoid spinal
RxNorm normalized name: bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subarachnoid spinal analgesia with morphine sulfate (Group A)
Trial: 373871
Drug: ampicillin (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ampicillin (12 g/d)
Trial: 373871
Drug: clindamycin (2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: clindamycin (2.4 g/d) plus gentamicin (5.1 mg/kg daily)
Trial: 30972991
Drug: Partial submergence
RxNorm normalized name: rosin partially dimerized glycerol ester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partial submergence treatment for 20 days
Trial: 21721594
Drug: Diazepam autoinjector
RxNorm normalized name: Diazepam Autoinjector
DrugBank: Diazepam (DB00829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diazepam autoinjector (10 mg)
Trial: 21721594
Drug: Diazepam rectal
RxNorm normalized name: diazepam Rectal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam rectal gel (10 mg)
Trial: 19453040
Drug: Continuous 5-FU
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Continuous 5-FU infusion (333 mg/m2/day for 7 days starting from the day of surgery) + oral HCFU (300 mg/day for 2 years starting 2 weeks after surgery) in Group B
Trial: 19453040
Drug: Oral HCFU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral HCFU (300 mg/day for 2 years starting 2 weeks after surgery) in Group A
Trial: 15063918
Drug: Court-ordered disulfiram
RxNorm normalized name: Disulfiram
DrugBank: Disulfiram (DB00822)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Court-ordered disulfiram treatment
Trial: 15063918
Drug: Voluntary disulfiram
RxNorm normalized name: Disulfiram
DrugBank: Disulfiram (DB00822)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Voluntary disulfiram treatment
Trial: 9018023
Drug: Gum containing
RxNorm normalized name: CONTAINER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gum containing 200 mg theanine
Trial: 7688204
Drug: 0.1% 13-cis-retinoic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% 13-cis-retinoic acid cream
Trial: 7688204
Drug: Cream base
RxNorm normalized name: Cream Base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream base only (Control)
Trial: 27746523
Drug: Granisetron 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 0.05 mg/kg
Trial: 27746523
Drug: Palonosetron 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron 1.5 mcg/kg
Trial: 24654464
Drug: Diphereline (GnRH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphereline (GnRH agonist)
Trial: 24654464
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no GnRH agonist)
Trial: 18671458
Drug: Apricitabine 1200
RxNorm normalized name: Emtricitabine
DrugBank: Emtricitabine (DB00879)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Apricitabine 1200 mg administered after fasting
Trial: 18671458
Drug: Apricitabine 1200
RxNorm normalized name: Emtricitabine
DrugBank: Emtricitabine (DB00879)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Apricitabine 1200 mg administered after a high-fat meal
Trial: 18671458
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of fasting vs high-fat meal administration
Trial: 10658408
Drug: Intravenous ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketamine 100 mg before surgical incision (group-K1)
Trial: 10658408
Drug: Intravenous ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketamine after laparotomy (group-K2)
Trial: 10848653
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg b.d.
Trial: 9690720
Drug: Lansoprazole 15
RxNorm normalized name: lansoprazole 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 15 mg b.d.
Trial: 7495944
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg b.d., intravenous drip infusion
Trial: 7495944
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg b.d., bolus injection
Trial: 26658126
Drug: Weight-based dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight-based dosing of 0.5 mg kg(‐1) twice daily
Trial: 26658126
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose of 40 mg daily
Trial: 20213013
Drug: Mucoadhesive lipid-based
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mucoadhesive lipid-based bioerodable tablet
Trial: 18413214
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of vitamins B(1) and B(6) tablets
Trial: 15814161
Drug: Reboxetine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reboxetine (4 mg, twice daily, for 16 weeks)
Trial: 12219852
Drug: Resistance treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistance treatment to deceptive persuasive messages
Trial: 12219852
Drug: Resistance treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistance treatment
Trial: 8966498
Drug: Intermittent cyclic
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent cyclic therapy (ICT) with etidronate
Trial: 6670855
Drug: 5% acyclovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% acyclovir in an aqueous cream base
Trial: 30859993
Drug: Transcranial Magnetic
RxNorm normalized name: transcranial magnetic stimulator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial Magnetic Stimulation (TMS) treatment
Trial: 30859993
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy (not performed)
Trial: 28344176
Drug: Stereotactic radiosurgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic radiosurgery (SRS) with a margin dose >20 Gy
Trial: 28344176
Drug: Stereotactic radiosurgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic radiosurgery (SRS) with a margin dose ≤20 Gy
Trial: 27123421
Drug: Dexmedetomidine (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (loading dose 1 μg/kg over 15 minutes, maintenance 0.5 μg/kg/h)
Trial: 27123421
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (loading dose 50 mg/kg over 15 minutes, maintenance 15 mg/kg/h)
Trial: 24268564
Drug: Rothschild Scale
RxNorm normalized name: wing scale pollen extract
DrugBank: Atriplex canescens pollen (DB10767)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rothschild Scale for Antidepressant Tachyphylaxis® (RSAT)
Trial: 24854458
Drug: Extended release
RxNorm normalized name: Tylenol Extended Release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended release niacin combined with laropiprant (ERN-L)
Trial: 12452452
Drug: Doxorubicin at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin at 80 mg/m2 x 3, followed by paclitaxel at 140 mg/m2 over 96 h x 3, then 5‐FU at doses of 1285, 1470, or 1655 mg/m2 by continuous intravenous infusion over 72 h x 3
Trial: 19767092
Drug: Dose-dense regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-dense regimen
Trial: 1953964
Drug: Tetrahydroaminoacridine (THA)
RxNorm normalized name: Tetrahydroaminoacridine
DrugBank: Tacrine (DB00382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetrahydroaminoacridine (THA) treatment during inpatient phase
Trial: 1953964
Drug: Long-term outpatient
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term outpatient treatment with THA
Trial: 31505491
Drug: Topical cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclosporine A (CsA) administered for 12 months after engraftment
Trial: 26313245
Drug: Topical cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclosporine A (CsA)
Trial: 27078993
Drug: Control (conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (conventional drug therapy)
Trial: 17936382
Drug: Impairment in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Impairment in activities of daily living (ADL)
Trial: 15126518
Drug: Buccal system
RxNorm normalized name: Striant 30mg Buccal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal system (Striant), applied twice daily for 7 days
Trial: 15126518
Drug: Transdermal patch
RxNorm normalized name: TRANSDERMAL PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal patch (Andropatch or Androderm), applied daily for 7 days
Trial: 7898078
Drug: Simvastatin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 2.5 mg
Trial: 10563066
Drug: Cerivastatin 0.2
RxNorm normalized name: cerivastatin 0.2 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin 0.2 mg
Trial: 7975414
Drug: Diet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet therapy with additional provision of vegetables, fruit, and greens
Trial: 3547009
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g of glucose in 350 ml of water (GLU)
Trial: 3547009
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g of fructose in 350 ml of water (FRU)
Trial: 3547009
Drug: 350 ml
RxNorm normalized name: Nutrilipid 20 % in 350 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 350 ml of an artificially sweetened and flavored placebo (CON)
Trial: 30580490
Drug: Activated carbon
RxNorm normalized name: Activated carbon
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated carbon nanoparticles (ACNs) injection (1 ml) in the subserosa around the tumour before colectomy and D3 lymphadenectomy.
Trial: 30580490
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no ACN injection).
Trial: 30580490
Drug: Activated carbon
RxNorm normalized name: Activated carbon
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated carbon nanoparticles (ACNs) injection.
Trial: 26427723
Drug: Trivalent-inactivated vaccine
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent-inactivated vaccine
Trial: 26427723
Drug: Live-attenuated vaccine
RxNorm normalized name: Chikungunya vaccine (live, attenuated)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live-attenuated vaccine
Trial: 23121733
Drug: CKD‐EPI eGFR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CKD‐EPI eGFR <60 mL/min/1.73m2
Trial: 23121733
Drug: Albuminuria with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuminuria with eGFR ≥60 mL/min/1.73 m2
Trial: 23121733
Drug: MDRD related
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDRD related estimates for eGFR <60 mL/min/1.73 m2
Trial: 19708471
Drug: Qigong Sensory
RxNorm normalized name: aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Qigong Sensory Training (QST) - a qigong massage intervention, involving 20 sessions over 5 months, with daily parental massage.
Trial: 18165528
Drug: Levamisole administered
RxNorm normalized name: Levamisole
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levamisole administered bimonthly to 107 subjects
Trial: 18165528
Drug: Levamisole administered
RxNorm normalized name: Levamisole
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levamisole administered to children 5-14 years
Trial: 3584580
Drug: PA Patch
RxNorm normalized name: Patch
DrugBank: Lavender oil (DB14566)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PA Patch
Trial: 31478095
Drug: High-Intensity Laser
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Intensity Laser Therapy (HILT) + Exercise
Trial: 28901958
Drug: Montmorency tart
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montmorency tart cherry juice (240 mL 2 times/d for 2 weeks)
Trial: 24763930
Drug: Rivaroxaban 20
RxNorm normalized name: rivaroxaban 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 20 mg once daily; 15 mg once daily for creatinine clearance of 30‐49 mL/min
Trial: 20544937
Drug: Intramuscular BoNT‐A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular BoNT‐A injections at 6‐month intervals in the tibialis posterior and peroneus longus.
Trial: 20544937
Drug: Control leg
RxNorm normalized name: Crab leg
DrugBank: Crab leg (DB11011)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control leg received no injections.
Trial: 17061020
Drug: Percussive ventilation
RxNorm normalized name: VENTILATOR FILTER,THERMOFLO #6000S
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percussive ventilation (IMP2 Breas, Sweden) 10 min twice/day in addition to chest physiotherapy
Trial: 14581257
Drug: Dedicated medication
RxNorm normalized name: liver,desiccated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dedicated medication nurses
Trial: 14581257
Drug: Dedicated medication
RxNorm normalized name: liver,desiccated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dedicated medication nurses at hospital B
Trial: 14581257
Drug: Dedicated medication
RxNorm normalized name: liver,desiccated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dedicated medication nurses at hospital A
Trial: 14581257
Drug: Dedicated medication
RxNorm normalized name: liver,desiccated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dedicated medication nurses in surgical units at hospital A
Trial: 14581257
Drug: Dedicated medication
RxNorm normalized name: liver,desiccated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dedicated medication nurses in medical units
Trial: 1573544
Drug: Citric acid
RxNorm normalized name: Citric Acid
DrugBank: Citric acid (DB04272)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citric acid treatment for 30, 60, 120, or 240 seconds
Trial: 1573544
Drug: Tetracycline HCl
RxNorm normalized name: tetracycline HCl
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracycline HCl treatment for 30, 60, 120, or 240 seconds
Trial: 3933330
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V given twice daily (250 mg for ten days)
Trial: 3933330
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V given three times daily (250 mg for ten days)
Trial: 24619932
Drug: LY2456302 (2-60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2456302 (2-60 mg single doses)
Trial: 24619932
Drug: LY2456302 (2,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2456302 (2, 10, and 35 mg multiple doses)
Trial: 24619932
Drug: LY2456302 co-administered
RxNorm normalized name: CO
DrugBank: Carbon monoxide (DB11588)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2456302 co-administered with ethanol
Trial: 20076848
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg daily for five days
Trial: 20076848
Drug: Aspirin 325
RxNorm normalized name: aspirin 325 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 325 mg daily for five days
Trial: 9502680
Drug: Pulse-spray thrombolysis
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulse-spray thrombolysis with high-dose urokinase
Trial: 9502680
Drug: Continuous-infusion thrombolysis
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous-infusion thrombolysis with high-dose urokinase
Trial: 7633701
Drug: Epinephrine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine (2 mg bolus followed by 2 mg every 4 min)
Trial: 7633701
Drug: Methoxamine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methoxamine (40 mg bolus followed after 4 min by 40 mg)
Trial: 2520343
Drug: Inhaled budesonide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide, daily dose 4 x 0.1 mg for 6 weeks
Trial: 20284
Drug: Clorazepate 15
RxNorm normalized name: clorazepate 15 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clorazepate 15 mg at bedtime
Trial: 20284
Drug: Diazepam thrice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam thrice daily
Trial: 26416334
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy with booster sessions
Trial: 26416334
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy plus manual therapy
Trial: 26416334
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy plus manual therapy with booster sessions
Trial: 30545387
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy (control group)